NCT04206657View on ClinicalTrials.gov

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

June 17, 2021

Study Completion Date

June 17, 2021

Conditions
Healthy Volunteer
Interventions
DRUG

1mg KHK7580

Single oral dose administration of 1mg KHK7580

DRUG

3mg KHK7580

Single oral dose administration of 3mg KHK7580

DRUG

6mg KHK7580

Single oral dose administration of 6mg KHK7580

DRUG

12mg KHK7580

Single oral dose administration of 12mg KHK7580

DRUG

6mg KHK7580 for 8days

multiple oral dose administration of 6mg KHK7580 for 8days

Trial Locations (1)

Unknown

Beijing hospital, Beijing

All Listed Sponsors
collaborator

Kyowa Kirin China Pharmaceutical Co., Ltd.

INDUSTRY

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT04206657 - Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter